28 February 2023: Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, have announced a new partnership to jointly market DENARASE® products. The DENARASE® product family was launched in 2012 and applied in hundreds of clinical and commercial production processes for gene/cell therapies and vaccines. Combining Kerry and c-LEcta’s expertise in the biopharma and pharmaceutical sectors, the partnership will … [Read more...] about Kerry and c-LEcta enter agreement to market DENARASE® products
c-LEcta
Kerry to acquire biotechnology innovation companies
Taste and nutrition company Kerry announced that it has reached agreements to acquire two leading biotechnology companies: c-LEcta and Enmex. These acquisitions are set to expand Kerry’s expertise, manufacturing capacities and tech portfolio. Germany-based c-LEcta produces high-value targeted enzymes and ingredients, with its functional bioactives utilised in the food and beverage space. It focuses on precision fermentation, optimised bio-transformation and bio-processing. On the other … [Read more...] about Kerry to acquire biotechnology innovation companies
